Panome Bio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Panome Bio's estimated annual revenue is currently $1.7M per year.(i)
  • Panome Bio's estimated revenue per employee is $77,500

Employee Data

  • Panome Bio has 22 Employees.(i)
  • Panome Bio grew their employee count by 214% last year.

Panome Bio's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Co-Founder, President, and COOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$79.1M5106%N/AN/A
#2
$1.1M717%N/AN/A
#3
$4.2M27-32%N/AN/A
#4
$2M1330%N/AN/A
#5
$4.3M284%N/AN/A
#6
$0.9M60%N/AN/A
#7
$5M323%N/AN/A
#8
$3.7M244%N/AN/A
#9
$0.3M40%N/AN/A
#10
$6M3950%N/AN/A
Add Company

What Is Panome Bio?

Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems. We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic’s SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$1.7M

Revenue (est)

214%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M22-15%N/A
#2
N/A22-27%N/A
#3
$2.3M23-12%N/A
#4
$2.4M24-11%N/A
#5
$6M24-8%N/A